Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1102 | 933 | 1184 | 1184 | 1493 | 2070 |
Fund Return | 10.19% | -6.67% | 18.36% | 5.78% | 8.35% | 7.55% |
Place in category | 187 | 417 | 170 | 40 | 58 | 69 |
% in Category | 16 | 46 | 16 | 4 | 11 | 22 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Balanced Fund A USD Acc | 8.94B | 16.20 | 3.74 | 7.13 | ||
Janus Balanced Fund I USD Acc | 8.94B | 17.30 | 4.82 | 8.18 | ||
Janus Global Life Sciences Fund I U | 3.98B | 11.02 | 6.65 | 8.39 | ||
Janus Global Technology Fund A USD | 526.76M | 31.84 | 7.00 | 16.96 | ||
Janus Global Technology Fund I USD | 526.76M | 32.84 | 7.89 | 17.93 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund I U | 3.98B | 11.02 | 6.65 | 8.39 | ||
Wellington Global Health Care EquiN | 2.06B | 5.18 | 1.37 | 7.49 | ||
Wellington Global Health Care EquiD | 2.06B | 4.56 | 0.72 | 6.80 | ||
Wellington Global Health Care EquUG | 2.06B | 5.66 | 1.88 | 8.04 | ||
Wellington Global Health Care EquiS | 2.06B | -2.69 | -2.90 | 6.48 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.62 | 823.23 | +2.38% | |
UnitedHealth | US91324P1021 | 6.78 | 545.57 | +1.39% | |
Novo Nordisk B | DK0062498333 | 4.46 | 611.9 | +1.36% | |
AbbVie | US00287Y1091 | 3.79 | 175.65 | +0.22% | |
AstraZeneca | GB0009895292 | 3.52 | 11,340.0 | +0.23% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Neutral | Strong Buy |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review